Literature DB >> 10429758

Prostate-specific antigen for prostate cancer screening. Do physician characteristics affect its use?

K L Edlefsen1, M T Mandelson, M W McIntosh, M R Andersen, E H Wagner, N Urban.   

Abstract

PURPOSE: Screening for prostate cancer with the prostate-specific antigen (PSA) test remains controversial. This controversy is reflected in a lack of consensus in the medical literature and among professional and policy organizations regarding routine screening by PSA. It is not known how physicians respond when recommendations from experts are inconsistent.
METHODS: A questionnaire was mailed to 1369 primary care physicians in active practice in Washington State in 1994. Response rate to the survey was 63%. Chi-square tests and multivariate logistic regression analysis were used to examine the effects of physician characteristics on physicians' self report of use of the PSA test for screening asymptomatic male patients, aged 50 to 80, for prostate cancer.
RESULTS: Of the 714 physicians included in the analysis, 68% reported routine use of PSA. Use of PSA varied among physicians on the basis of practice setting, years since medical school graduation, and whether compensation was fee-for-service or salaried. Male physicians trained before 1974 and physicians receiving fee-for-service were significantly more likely than other physicians to recommend screening by PSA.
CONCLUSIONS: Results suggest that physicians' personal characteristics such as year of medical school graduation, gender, and mode of reimbursement are related to self-reported PSA use.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10429758     DOI: 10.1016/s0749-3797(99)00041-0

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  10 in total

1.  Adoption of liquid-based cervical cancer screening tests by family physicians and gynecologists.

Authors:  Karen M Rappaport; Christopher B Forrest; Neil A Holtzman
Journal:  Health Serv Res       Date:  2004-08       Impact factor: 3.402

2.  Healthcare practices among blacks and whites with urinary tract symptoms.

Authors:  Daniel L Howard; Bennett G Edwards; Kimberly Whitehead; M Ahinee Amamoo; Paul A Godley
Journal:  J Natl Med Assoc       Date:  2007-04       Impact factor: 1.798

3.  Prostate cancer screening practices and beliefs.

Authors:  J D Voss; J M Schectman
Journal:  J Gen Intern Med       Date:  2001-12       Impact factor: 5.128

4.  Comparison of hospitalists and nonhospitalists in inpatient length of stay adjusting for patient and physician characteristics.

Authors:  William D Rifkin; Eric Holmboe; Hannah Scherer; Hernan Sierra
Journal:  J Gen Intern Med       Date:  2004-11       Impact factor: 5.128

5.  Biopsy follow-up of prostate-specific antigen tests.

Authors:  Steven B Zeliadt; Diana S M Buist; Robert J Reid; David C Grossman; Jian Ma; Ruth Etzioni
Journal:  Am J Prev Med       Date:  2012-01       Impact factor: 5.043

6.  Learning amid controversy: prostate cancer knowledge and screening practices among US medical students.

Authors:  David M Werny; Mona Saraiya; Jennifer Carrera; Steven S Coughlin; Erica Frank
Journal:  J Cancer Educ       Date:  2008       Impact factor: 2.037

7.  Prostate-specific antigen testing among the elderly in community-based family medicine practices.

Authors:  Shawna V Hudson; Pamela Ohman-Strickland; Jeanne M Ferrante; Grace Lu-Yao; A John Orzano; Benjamin F Crabtree
Journal:  J Am Board Fam Med       Date:  2009 May-Jun       Impact factor: 2.657

8.  Effect of guidelines on primary care physician use of PSA screening: results from the Community Tracking Study Physician Survey.

Authors:  Carmen E Guerra; Phyllis A Gimotty; Judy A Shea; José A Pagán; J Sanford Schwartz; Katrina Armstrong
Journal:  Med Decis Making       Date:  2008-06-12       Impact factor: 2.583

9.  Physician factors as an indicator of technological device adoption.

Authors:  LaToya C Artis; Theresa M Burkhart; Tricia J Johnson; Karl A Matuszewski
Journal:  J Med Syst       Date:  2006-06       Impact factor: 4.920

10.  Prostate specific antigen testing in family practice: a cross sectional survey of self-reported rates of and reasons for testing participation and risk disclosure.

Authors:  Mariko Carey; Jamie Bryant; Sze Lin Yoong; Grant Russell; Daniel Barker; Rob Sanson-Fisher
Journal:  BMC Fam Pract       Date:  2013-12-09       Impact factor: 2.497

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.